These results suggest that JGXZ inhibits oxidative stress and apoptosis in NAFLD by downregulating the protein expressions of Fas and cytochrome C in the liver tissues. The gene discussed is FAS; the disease is metabolic dysfunction-associated steatotic liver disease.